US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Drug Discovery: market research reports

RSS Feeds

Drug Discovery market research reports and industry analysis

1  2  3  4    6    8  9  10  
Cellular Therapy in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... the accumulated number of ceased drugs over the last years amount to another 64 drugs. Cellular Therapy In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of ...  |  read more...
USD 4,496
Breast Cancer Drug Pathway Analyzer 2014
7/15/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of breast cancer. The rational for this plethora of treatment strategies is based on our increasing understanding of the 290 drug targets that are included in this drug-pathway analyzing ...  |  read more...
USD 6,746
Liver Cancer Drug Pathway Analyzer 2014
7/15/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of liver cancer. The rational for this plethora of treatment strategies is based on our increasing understanding of the 173 drug targets that are included in this drug-pathway analyzing ...  |  read more...
USD 4,496
The MAPK Signaling Pathway in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... There are today 236 companies plus partners developing 335 The MAPK signaling pathway targeting drugs in 1261 developmental projects in cancer. In addition, there are 3 suspended drugs and the accumulated number of ceased drugs ...  |  read more...
USD 6,746
Gap Junctions in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... 'hemichannels', each containing six connexins, contributed by each neighboring cell. These channels permit the direct transfer of small molecules including ions, amino acids, nucleotides, second messengers and other metabolites between adjacent cells. Gap junctional communication ...  |  read more...
USD 6,746
Gene Therapy in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... the accumulated number of ceased drugs over the last years amount to another 97 drugs. Gene Therapy In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of ...  |  read more...
USD 6,746
Head and Neck Cancer Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... accumulated number of ceased drugs over the last years amount to another 48 drugs. Head And Neck Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. ...  |  read more...
USD 6,746
Hedgehog Signaling Pathway in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... today 119 companies plus partners developing 168 Hedgehog pathway targeting drugs in 673 developmental projects in cancer. In addition, there are 3 suspended drugs and the accumulated number of ceased drugs over the last years ...  |  read more...
USD 6,746
HIF-1 Signaling Pathway in Cancer Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... (O(2)) and nutrient availability. The hypoxia-inducible factors (HIFs) are a common link between adaptation to low O(2), changes in cancer metabolism, and malignant progression. This report focusses around the cancer drugs targeting the hypoxia-inducible factor ...  |  read more...
USD 6,746
IL-1 Signaling Pathway in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... the MAPK signaling module and activate NFkB, they are synergistic and complement each other's activity. There are today 85 companies plus partners developing 84 IL-1 pathway targeting drugs in 313 developmental projects in cancer. In ...  |  read more...
USD 4,496
IL-3 Signaling Pathway in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... drugs in 971 developmental projects in cancer. In addition, there are 3 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 106 drugs. Il-3 Signaling Pathway In Oncology ...  |  read more...
USD 6,746
Insomnia Global Clinical Trials Review, H2, 2014
7/14/2014 | published by: GlobalData
... relating to the clinical trials on Insomnia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage ...  |  read more...
USD 2,500
Global Rheumatoid Arthritis Drugs Market : 2014-2018
7/14/2014 | published by: TechNavio - Infiniti Research Ltd.
... AbbVie Inc., Amgen Inc., Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., Janssen Pharmaceuticals Inc., Pfizer Inc. , AB Science SA, Astellas Pharma Inc., AstraZeneca plc, Biogen Idec Inc., Boehringer Ingelheim GmbH, Celgene Corp., Daiichi Sankyo ...  |  read more...
USD 2,500
OpportunityAnalyzer: Cystic Fibrosis - Opportunity Analysis and Forecasts to 2018 - Event-Driven Update
7/7/2014 | published by: GlobalData
... and leads to life-threatening lung infections; and obstructs pancreatic enzyme secretions that are essential for the body to break down and absorb nutrients. CF patients have a limited number of available treatment options and significant ...  |  read more...
USD 5,995
Global Macular Edema Market : 2014-2018
7/7/2014 | published by: TechNavio - Infiniti Research Ltd.
... F. Hoffmann-La Roche Ltd., Novartis AG, Regeneron Pharmaceuticals Inc., Alcon Inc., Alimera Sciences Inc., Allergan Inc., Ampio Pharmaceuticals Inc., iCo Therapeutics Inc.,Pfizer Inc., Santen Pharmaceutical Co. Ltd. Commenting on the report, an analyst from TechNavio‚Äôs ...  |  read more...
USD 2,500
A Global Product and Pipeline Analysis of Antiretroviral Drug Development for the Treatment of HIV/AIDS
7/3/2014 | published by: Frost & Sullivan
... treatment of HIV infection, marked an important advancement in antiretroviral therapy (ART), significantly enhancing efficacy and reducing pill burden. Research has continued to build on this innovation, and patients now have at their disposal a ...  |  read more...
USD 4,000
Cell Culture Market by Equipment (Bioreactor, Incubator, Centrifuge), by Reagent (Media, Sera, Growth Factors, Serum Free Media), by Application (Cancer Research, Gene Therapy, Drug Development, Vaccine Production, Toxicity Testing) - Global Forecast to 2
7/1/2014 | published by: MarketsandMarkets
... The report segments the cell culture market into two distinct market segments, namely, the cell culture equipment market and the cell culture media, sera, and reagents market. The segments of the cell culture equipment market ...  |  read more...
USD 4,650
Botulinum Neurotoxins: A comparative industry analysis of products, pipelines, technologies and stakeholders
7/1/2014 | published by: La Merie Publishing
... identification, description and assessment of all relevant stakeholders in the field of botulinum neurotoxins. The report analyzes the existing product portfolios in regulated and less regulated markets, commercial information, and measures to maintain sales and ...  |  read more...
USD 2,656
Emerging Pharmaceuticals Markets - China
7/1/2014 | published by: Asia Market Information & Development Company
... new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and ...  |  read more...
USD 4,000
Competitor Analysis: alpha1-Proteinase Inhibitors (alpha1-PI), alpha1-Antitrypsin (AAT) and Elastase Inhibitors
7/1/2014 | published by: La Merie Publishing
... recombinant, transgenic, synthetic and gene therapeutic approaches for treatment of lung emphysema caused by congenital deficiency and of other diseaes by synthetic elastase inhibitors or RNA approaches as of July 2014. Purchase of the downloadable ...  |  read more...
USD 272
Allergic Asthma - Pipeline Review, H1 2014
6/30/2014 | published by: Global Markets Direct
... therapeutic development for Allergic Asthma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Anxiety Disorders - Pipeline Review, H1 2014
6/30/2014 | published by: Global Markets Direct
... therapeutic development for Anxiety Disorders, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Bacterial Conjunctivitis - Pipeline Review, H1 2014
6/30/2014 | published by: Global Markets Direct
... therapeutic development for Bacterial Conjunctivitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Bone Degeneration - Pipeline Review, H1 2014
6/30/2014 | published by: Global Markets Direct
... therapeutic development for Bone Degeneration, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Cancer Cachexia - Pipeline Review, H1 2014
6/30/2014 | published by: Global Markets Direct
... therapeutic development for Cancer Cachexia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
1  2  3  4    6    8  9  10